Corbus Pharmaceuticals Holdings, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Norwood, MA
CRBP chart
What traders are saying about $CRBP
Latest postsCorbus Pharmaceuticals Holdings, Inc. news
- Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day
MarketWatch ·
- Corbus Pharmaceuticals Holdings, Inc. Estimates – NASDAQ:CRBP
TradingView ·
- Corbus Pharmaceuticals Holdings Stock Price Forecast. Should You Buy CRBP?
StockInvest.us ·
- Corbus Pharmaceuticals develops CRB-913 to target obesity by blocking peripheral CB1 receptors
Traders Union ·
- Corbus Pharmaceuticals to Present Late Breaking CRB-913 Data from Canyon-1 Study at Obesity Week® 2026
Yahoo Finance ·
- Corbus (CRBP) Stock: Slides -0.90% — Support Test Looms at $4.20 2026-10-20 - VWAP Bounce
www.dars.gov.et ·
- Corbus Pharmaceuticals Announces First Patient Dosed in TEMPO-1 Registrational Study of CRB-701 in Patients with 2L+ Oropharyngeal Cancer
Yahoo Finance ·
- Is CRBP a Good Cannabis Investment After Positive Obesity Study Data?
Yahoo Finance ·
- Corbus CRB-913 Delivers 5% Weight Loss in Phase 1b Obesity Study
marketbeat.com ·
- Corbus Pharmaceuticals Shares Rise 12% After CANYON-1 Obesity Trial Data
investorshub.advfn.com ·
- Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
Yahoo Finance ·
- Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
Yahoo Finance ·
Corbus Pharmaceuticals Holdings, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $0 |
| Net income | -$78.5M | -$40.2M | -$44.6M | -$42.3M |
| Diluted EPS | $-5.90 | $-3.68 | $-10.31 | $-10.15 |
| Total assets (year end) | $168.2M | $155.9M | $28.3M | $66.3M |
| Cash and equivalents (year end) | $28.5M | $17.2M | $13.7M | $17.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Corbus Pharmaceuticals Holdings, Inc.
- Ticker
- CRBP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Norwood, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1595097
- Former names
- SAV Acquisition Corp
Frequently asked questions
What exchange is Corbus Pharmaceuticals Holdings, Inc. listed on?
Corbus Pharmaceuticals Holdings, Inc. trades on the Nasdaq under the ticker symbol CRBP.
What industry is Corbus Pharmaceuticals Holdings, Inc. in?
Corbus Pharmaceuticals Holdings, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Corbus Pharmaceuticals Holdings, Inc. headquartered?
Corbus Pharmaceuticals Holdings, Inc.'s business address on file with the SEC is in Norwood, MA.
When does Corbus Pharmaceuticals Holdings, Inc.'s fiscal year end?
Corbus Pharmaceuticals Holdings, Inc.'s fiscal year ends on December 31.
How much revenue did Corbus Pharmaceuticals Holdings, Inc. report?
Corbus Pharmaceuticals Holdings, Inc. reported $0 in revenue for calendar year 2022, according to its SEC filings.